NLS

MedTech Business - September 23, 2014

Mega Electronics gains distribution in China

Finnish health technology company Mega Electronics has signed a co-operation agreement with two Chinese medical device companies.  Huafu Medical and Mercer Medical will start distribution of Mega Electronics’ remote-readable Faros ECG monitoring devices, reports Good News Finland. The Faros monitoring device is used to measure a person’s ECG. The goal is to  a comprehensive distribution network for the product among China’s […]

Clinical Trials - September 22, 2014

Umecrine Mood announces positive results

The company has announced positive results from an exploratory Phase I/II study with UC1010 in premenstrual dysphoric disorder (PMDD). On September 19 Umecrine Mood announced the final results from an exploratory randomized Phase I/II study with its candidate drug UC1010 in patients with PMDD. The company states that the results show a statistically significant improvement of […]

Collaboration - September 22, 2014

Sobi collaborates with Biogen Idec

Sobi is planning to include a new preclinical hemophilia project in an agreement with Biogen Idec. Accodring to an announcement, Sobi has elected to add the preclinical rFVIIIFc-XTEN-vWF fusion molecule to the company’s collaboration with Biogen Idec. The XTEN technology is proprietary to Amunix Operating, Inc.. Biogen Idec and Amunix signed a worldwide license agreement […]

Financing - September 22, 2014

Recipharm secures financing

The company has entered a new five-year SEK 1 500 million loan facility with three of the largest banks in Scandinavia for continued growth. The revolving credit facility of SEK 1 500 million is signed with DNB, Handelsbanken and Swedbank and will serve as an additional resource to facilitate future expansion plans set in place for the business, […]

Regulatory compliance - September 19, 2014

Novo Nordisk in million dollar settlement

Danish Novo Nordisk has reached a settlement with the American sales company Rocheset Drug regarding the diabetes substance Prandin. Novo Nordisk has agreed to pay USD 19 million according to the agreement. The reason behind the disagreement is a lawsuit from Rocheset Drug in January 2014. The American sales company demanded compensation for lost sales […]

Acquisition - September 18, 2014

Addvise acquires Surgical Tables Inc

Addvise Lab Solutions AB has entered into an agreement to acquire Surgical Tables Inc for SEK 18.2 million. The agreement is planned to be effective November 1, 2014. Approximately SEK 5,5 million will be paid in cash at closing and approximately SEK 5,5 million is paid in newly issued shares or in cash at closing. Also, approximately SEK […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.